Product
HAIC+PD1
1 clinical trial
1 indication
Indication
Hepatocellular CarcinomaClinical trial
Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitor in Treating Potentially Resectable Locally Advanced Hepatocellular Carcinoma: A Prospective, Phase II Clinical StudyStatus: Active (not recruiting), Estimated PCD: 2020-07-20